Skip to the page

Data / Drug companies / Noon Aesthetics M.R. Ltd

Noon Aesthetics M.R. Ltd: 21 products in the FDA NDC directory, labeler code 78863

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Noon Aesthetics M.R. Ltd (labeler code 78863) lists 21 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 21 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on April 24, 2026.

The request: Watch Noon Aesthetics M.R. Ltd (FDA labeler code 78863): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
78863
Products in commercial distribution
21
Packages
36
Finished drugs by generic name
6
Prescription products
0
Over the counter products
21
Flagged as original packager
21 of 21 products that carry the flag
Started marketing in the last 12 months
1
Earliest marketing start
January 5, 2020
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs21100%

Products by type

TypeProductsShare
Over the counter drugs21100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Salicylic acid5330
Benzoyl peroxide382
Allantoin, titanium dioxide, octocrylene, and avobenzone21
Allantoin131
Salicylic acid and benzoyl peroxide12
Titanium dioxide, octocrylene, and avobenzone11

Dosage forms

Dosage formProductsShare
Cream942.9%
Powder838.1%
Kit314.3%
Soap14.8%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
CosmoClear Cleanser78863-3025SoapOver the counter monograph drugsApril 24, 2026
ACNO Solution ACNE TREATMENT78863-3002CreamOver the counter monograph drugsJune 15, 2024
Lacto-s acne treatment78863-3001CreamOver the counter monograph drugsJune 10, 2024
BRUSH and GO SPF 50 OILY/PROBLEMATIC SKIN BROAD SPECTRUM78863-3004PowderOver the counter monograph drugsApril 1, 2024
BRUSH and GO SPF 50 ALL SKIN TYPES BROAD SPECTRUM78863-3003PowderOver the counter monograph drugsApril 1, 2024
BenzoAzeline 1078863-1310CreamOver the counter monograph drugsMarch 1, 2024
BenzoAzeline 578863-1300CreamOver the counter monograph drugsMarch 1, 2024
NOON Cartessa Accelerate Program78863-2700KitOver the counter monograph drugsOctober 1, 2023
NOON Post Procedure Program78863-2600KitOver the counter monograph drugsOctober 1, 2023
DeFlame78863-1270CreamOver the counter monograph drugsOctober 1, 2023
Brush and Go Oily Problematic Skin Matte Finish Tone 278863-1017PowderOver the counter monograph drugsJanuary 1, 2023
Brush and Go Oily Problematic Skin Matte Finish Tone 178863-1016PowderOver the counter monograph drugsJanuary 1, 2023
Brush and Go All Skin types Matte Finish Tone 278863-1013PowderOver the counter monograph drugsJanuary 1, 2023
Brush and Go All Skin types Matte Finish Tone 178863-1011PowderOver the counter monograph drugsJanuary 1, 2023
Benzoazeline Forte78863-1180CreamOver the counter monograph drugsJanuary 9, 2022
AcNe solution78863-1220CreamOver the counter monograph drugsMay 1, 2020
Multivit Sun Protector78863-1110CreamOver the counter monograph drugsMay 1, 2020
Therapeutic Hydrogel78863-1090CreamOver the counter monograph drugsMay 1, 2020
Brush and Go Oily Problematic Skin78863-1012PowderOver the counter monograph drugsMay 1, 2020
Brush and Go All Skin types78863-1010PowderOver the counter monograph drugsMay 1, 2020
Double Fight78863-1040KitOver the counter monograph drugsJanuary 5, 2020

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.